Bank of Montreal
BLPH

Bank of Montreal’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Bank of Montreal’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-159
Closed -$1K – 5530
2021
Q1 		$1K Sell
159
-565
-78% -$3.94K ﹤0.01% 5035
2020
Q4 		$5K Buy
724
+515
+246% +$4.22K ﹤0.01% 4772
2020
Q3 		$2K Sell
209
-66
-24% -$776 ﹤0.01% 4672
2020
Q2 		$4K Buy
+275
New +$3.85K ﹤0.01% 4474

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bank of Montreal's BLPH Position: Q2 2021 in Review

Bank of Montreal sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2021, closing a stake of 159 shares — an estimated $1K sold.

Bank of Montreal first reported a position in BLPH in Q2 2020 and held it in 4 quarters. The position peaked at $5K in Q4 2020. 27 funds tracked by Wall St. Rank hold BLPH as of Q2 2021.

  • Bank of Montreal reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 159 Bellerophon Therapeutics, Inc. shares in Q2 2021, an estimated $1K.
  • Bank of Montreal first reported a position in Bellerophon Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • Bank of Montreal's Bellerophon Therapeutics, Inc. position peaked at $5K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.